Cynthia Madden
- Immunology top 5%
- Dermatology top 1%
- Rheumatology top 10%
- Pathology and Forensic Medicine top 10%
- Physiology
- Co-authors
- Andrew BlauveltChristopher L. CioffiVeerle VanvoordenKristian ReichMark LebwohlRichard B. WarrenRichard G. LangleyKenneth B. Gordon
- Topics
- Psoriasis: Treatment and Pathogenesis (11 papers)Autoimmune Bullous Skin Diseases (6 papers)Dermatology and Skin Diseases (5 papers)
- Cited by
- DermatologyImmunologyRheumatology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Cynthia Madden
19 papers receiving 847 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Immunology 602
- Dermatology 379
- Rheumatology 153
- Pathology and Forensic Medicine 151
- Physiology 107
Countries citing papers authored by Cynthia Madden
This map shows the geographic impact of Cynthia Madden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Madden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Madden more than expected).
Fields of papers citing papers by Cynthia Madden
This network shows the impact of papers produced by Cynthia Madden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Madden. The network helps show where Cynthia Madden may publish in the future.
Co-authorship network of co-authors of Cynthia Madden
This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Madden. A scholar is included among the top collaborators of Cynthia Madden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Madden. Cynthia Madden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trialsbreakdown → | 71 |
| 3 | 14 | |
| 4 | 16 | |
| 5 | 1 | |
| 6 | 18 | |
| 7 | Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trialbreakdown → | 169 |
| 8 | Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trialbreakdown → | 170 |
| 9 | Bimekizumab versus Secukinumab in Plaque Psoriasisbreakdown → | 230 |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 50 | |
| 13 | 2 | |
| 14 | 2 | |
| 15 | 30 | |
| 16 | 21 | |
| 17 | 34 | |
| 18 | 11 | |
| 19 | 18 | |
| 20 | 2 |
About Cynthia Madden
Cynthia Madden is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine, having authored 20 papers that have together received 862 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (11 papers), Autoimmune Bullous Skin Diseases (6 papers) and Dermatology and Skin Diseases (5 papers). The work is most often cited by research in Dermatology (379 citations), Immunology (602 citations) and Rheumatology (153 citations). Cynthia Madden has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrew Blauvelt, Christopher L. Cioffi, Veerle Vanvoorden, Kristian Reich, Mark Lebwohl, Richard B. Warren, Richard G. Langley, Kenneth B. Gordon, Dirk De Cuyper and Bruce Strober. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.